Deal or No Deal? What to Know About Dealmaking Post-Pandemic

11:05 AM - 11:50 AM (EDT), Tuesday, June 15, 2021
Search General Info
Search Education
Search Partnering Companies
COVID-19 disrupted the status quo for businesses across the industry—and led to a stark decline in M&A activity from previous years. But with unprecedented collaboration and innovation, companies have shown they can adapt to this new landscape. What do these challenges and adaptations mean for the future? Don’t make a deal before you hear what companies and investors are thinking about deal-making in 2021 and beyond.
Sponsored By
Moderator
photo
Executive Vice President, Strategy & Business Development
Bristol Myers Squibb Company
Speakers
photo
Founder and Managing General Partner
Samsara BioCapital
photo
Executive Vice President, Strategy & Business Development
Bristol Myers Squibb Company
photo
Executive Chairman
Remix Therapeutics
photo
Head of Immunology, CV & Fibrosis R&D and Head of Translational Medicine
Bristol Myers Squibb
photo
Vice Chairman, Investment Banking
J.P. Morgan